CLINICAL_TRIALS
withdrawal
· 2016-08-23
Clinical Trial Update: Effects of Paliperidone in Posttraumatic Stress Disorder (PTSD) [Phase 4]
Summary
A Phase 4 trial evaluating paliperidone for posttraumatic stress disorder has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Yale University | Conditions: Posttraumatic Stress Disorder | Phase 4 | Status: WITHDRAWN